Chemical and Biomolecular Engineering, Journal Year: 2024, Volume and Issue: 9(4), P. 52 - 61
Published: Dec. 25, 2024
Mushrooms have long been recognized for their nutritional and medicinal properties, but potential as sources of antimicrobial agents remains underexplored. This study investigates the activity various wild mushroom species against selected bacterial fungal pathogens. Specifically, focused on inhibition zones <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, <i>Candida albicans</i>, <i>Fusarium oxysporum</i>, proliferatum</i> when exposed to extracts from twelve different species, including <i>Schizophyllum commune</i>, <i>Laeiporus sulphureus</i>, <i>Pleurotus pulmonarius</i>, others. The results revealed significant antibacterial antifungal activities, with commune</i> showing highest oxysporum</i> (71.42 ± 0.28 mm) <i>Microporus xanthopus</i> demonstrating strong aureus</i> (8.46 0.11 mm). Additionally, sajor-caju</i> exhibited notable (76.06 0.14 mm), suggesting its a source novel compounds. observed varied range across emphasizing diverse within mycoflora. These findings underscore importance further research into bioactive compounds mushrooms, which could contribute development new agents. not only highlights significance mushrooms in combating microbial resistance also opens avenues inclusion future pharmaceutical applications.
Language: Английский